Patent · US Active

Fospropofol salts, methods and compositions

US12364704B2 · kind B2 · utility

0Cited by

21References

3Claims

0Family size

Assignee

EPALEX CORPORATION · US

Inventors

Randall B. Murphy · Glenmoore, US
Steven L. Krill · San Clemente, US
Samuel Andrew · Cambridge, GB

Key dates

Filing date	Dec 7, 2022
Grant date	Jul 22, 2025
Priority date	—
Expiry date	Dec 12, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.